Proteomics identifies differentially expressed proteins in glioblastoma U87 cells treated with hederagenin

OBJECTIVE: We investigated differentially expressed proteins (DEPs) in human glioblastoma U87 cells after treatment with hederagenin as a therapeutic screening mechanism and provided a theoretical basis for hederagenin in treating glioblastoma. METHODS: The Cell Counting Kit 8 assay was used to anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yesen, Han, Yi, Shang, Yuchun, Wang, Xiangyu, Sun, Jiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148390/
https://www.ncbi.nlm.nih.gov/pubmed/37120556
http://dx.doi.org/10.1186/s12953-023-00208-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148390/
https://www.ncbi.nlm.nih.gov/pubmed/37120556
http://dx.doi.org/10.1186/s12953-023-00208-7

Ejemplares similares